CXCL10 and neoplasm: The comparison between LL/2 and CT26 cell lines, representing immunotherapy-resistant and immunotherapy-sensitive tumors, respectively [24, 25], further supports the roles of IFNα and CXCL10 in mediating anti-tumor immunity.